These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16303301)

  • 21. Tricyclic pharmacophore-based molecules as novel integrin alphavbeta3 antagonists. Part IV: preliminary control of alphavbeta3 selectivity by meta-oriented substitution.
    Kubota D; Ishikawa M; Ishikawa M; Yahata N; Murakami S; Fujishima K; Kitakaze M; Ajito K
    Bioorg Med Chem; 2006 Jun; 14(12):4158-81. PubMed ID: 16504518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of a novel series of biphenyl benzoic acid derivatives as highly potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. Part II.
    Imanishi M; Itou S; Washizuka K; Hamashima H; Nakajima Y; Araki T; Tomishima Y; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F; Hattori K
    J Med Chem; 2008 Jul; 51(13):4002-20. PubMed ID: 18553954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hit-to-Lead studies: the discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists.
    Baxter A; Cooper A; Kinchin E; Moakes K; Unitt J; Wallace A
    Bioorg Med Chem Lett; 2006 Feb; 16(4):960-3. PubMed ID: 16297626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
    Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa).
    Podolnikova NP; Gorkun OV; Loreth RM; Yee VC; Lord ST; Ugarova TP
    Biochemistry; 2005 Dec; 44(51):16920-30. PubMed ID: 16363805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part I.
    Imanishi M; Tomishima Y; Itou S; Hamashima H; Nakajima Y; Washizuka K; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F; Hattori K
    J Med Chem; 2008 Mar; 51(6):1925-44. PubMed ID: 18307290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of +(2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid as potent and selective alphavbeta3 inhibitor: design, synthesis, and optimization.
    Nagarajan SR; Lu HF; Gasiecki AF; Khanna IK; Parikh MD; Desai BN; Rogers TE; Clare M; Chen BB; Russell MA; Keene JL; Duffin T; Engleman VW; Finn MB; Freeman SK; Klover JA; Nickols GA; Nickols MA; Shannon KE; Steininger CA; Westlin WF; Westlin MM; Williams ML
    Bioorg Med Chem; 2007 May; 15(10):3390-412. PubMed ID: 17387018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mechanistic model for paradoxical platelet activation by ligand-mimetic alphaIIb beta3 (GPIIb/IIIa) antagonists.
    Bassler N; Loeffler C; Mangin P; Yuan Y; Schwarz M; Hagemeyer CE; Eisenhardt SU; Ahrens I; Bode C; Jackson SP; Peter K
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):e9-15. PubMed ID: 17170374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P₁ agonists.
    Buzard D; Han S; Thoresen L; Moody J; Lopez L; Kawasaki A; Schrader T; Sage C; Gao Y; Edwards J; Barden J; Thatte J; Fu L; Solomon M; Liu L; Al-Shamma H; Gatlin J; Le M; Xing C; Espinola S; Jones RM
    Bioorg Med Chem Lett; 2011 Oct; 21(19):6013-8. PubMed ID: 21852130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of non-peptide alpha(v)beta(3)/alpha(5)beta(1) integrin dual antagonists containing 5,6-dihydropyridin-2-one scaffolds.
    Benfatti F; Cardillo G; Fabbroni S; Galzerano P; Gentilucci L; Juris R; Tolomelli A; Baiula M; Spartà A; Spampinato S
    Bioorg Med Chem; 2007 Dec; 15(23):7380-90. PubMed ID: 17869121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist.
    Cole DC; Stock JR; Lennox WJ; Bernotas RC; Ellingboe JW; Boikess S; Coupet J; Smith DL; Leung L; Zhang GM; Feng X; Kelly MF; Galante R; Huang P; Dawson LA; Marquis K; Rosenzweig-Lipson S; Beyer CE; Schechter LE
    J Med Chem; 2007 Nov; 50(23):5535-8. PubMed ID: 17948978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacophore model of integrin alphavbeta3 antagonists].
    Cheng GY; Ni GH; Jiang FC
    Yao Xue Xue Bao; 2009 Apr; 44(4):379-85. PubMed ID: 19545055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity.
    Fisher MJ; Backer RT; Barth VN; Garbison KE; Gruber JM; Heinz BA; Iyengar S; Hollinshead SP; Kingston A; Kuklish SL; Li L; Nisenbaum ES; Peters SC; Phebus L; Simmons RM; van der Aar E
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2514-7. PubMed ID: 22386665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonists.
    Gong Y; Barbay JK; Dyatkin AB; Miskowski TA; Kimball ES; Prouty SM; Fisher MC; Santulli RJ; Schneider CR; Wallace NH; Ballentine SA; Hageman WE; Masucci JA; Maryanoff BE; Damiano BP; Andrade-Gordon P; Hlasta DJ; Hornby PJ; He W
    J Med Chem; 2006 Jun; 49(11):3402-11. PubMed ID: 16722660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonpeptide alpha(v)beta3 antagonists: identification of potent, chain-shortened 7-oxo RGD mimetics.
    Zartman AE; Duong LT; Fernandez-Metzler C; Hartman GD; Leu CT; Prueksaritanont T; Rodan GA; Rodan SB; Duggan ME; Meissner RS
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1647-50. PubMed ID: 15745815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of small molecule integrin alphavbeta3 antagonists as novel anticancer agents.
    Dayam R; Aiello F; Deng J; Wu Y; Garofalo A; Chen X; Neamati N
    J Med Chem; 2006 Jul; 49(15):4526-34. PubMed ID: 16854058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for a differential functional regulation of the two beta(3)-integrins alpha(V)beta(3) and alpha(IIb)beta(3).
    Ahrens IG; Moran N; Aylward K; Meade G; Moser M; Assefa D; Fitzgerald DJ; Bode C; Peter K
    Exp Cell Res; 2006 Apr; 312(6):925-37. PubMed ID: 16434034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of potent and selective small-molecule human Urotensin-II antagonists.
    McAtee JJ; Dodson JW; Dowdell SE; Girard GR; Goodman KB; Hilfiker MA; Sehon CA; Sha D; Wang GZ; Wang N; Viet AQ; Zhang D; Aiyar NV; Behm DJ; Carballo LH; Evans CA; Fries HE; Nagilla R; Roethke TJ; Xu X; Yuan CC; Douglas SA; Neeb MJ
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3500-3. PubMed ID: 18502123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and structure-activity relationships of new disubstituted phenyl-containing 3,4-diamino-3-cyclobutene-1,2-diones as CXCR2 receptor antagonists.
    Lai G; Merritt JR; He Z; Feng D; Chao J; Czarniecki MF; Rokosz LL; Stauffer TM; Rindgen D; Taveras AG
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1864-8. PubMed ID: 18304809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human glucagon receptor antagonists with thiazole cores. A novel series with superior pharmacokinetic properties.
    Madsen P; Kodra JT; Behrens C; Nishimura E; Jeppesen CB; Pridal L; Andersen B; Knudsen LB; Valcarce-Aspegren C; Guldbrandt M; Christensen IT; Jørgensen AS; Ynddal L; Brand CL; Bagger MA; Lau J
    J Med Chem; 2009 May; 52(9):2989-3000. PubMed ID: 19385613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.